Centrus Energy Corp
Combined average of Moat (AI Resilience), Growth, and Valuation scores.
Moat Score
Centrus's moat rests on being the only US-owned-and-operated uranium enrichment technology and the first and sole NRC-licensed producer of HALEU in the Western world — a national-security barrier reinforced by a ~$3.8B contracted backlog stretching to 2040 and sole-source US Department of Energy funding for the Piketon, Ohio cascade.
Centrus owns the only domestic US uranium-enrichment capability at a moment when re-shoring the nuclear fuel cycle away from Russia's Rosatom has become explicit US energy and national-security policy:
- The Only Western HALEU Producer: High-Assay Low-Enriched Uranium (HALEU, 5–20% U-235) is the fuel required by nearly every advanced and small modular reactor design — Oklo, X-energy, TerraPower — yet before Centrus the only commercial supplier on Earth was Russia's Rosatom. Centrus is the first and only company to receive an NRC license to produce HALEU and the only Western enricher actually producing it at its Piketon, Ohio plant. That first-mover regulatory position, paired with a multi-year US Department of Energy production contract and a $900M task order (January 2026) to build commercial-scale capacity, makes Centrus the default fuel supplier for the entire Western SMR industry.
- American Centrifuge: Classified, Export-Controlled Technology: The AC100M centrifuge is the only US-origin enrichment machine and the only enrichment technology that is both American-owned and free of foreign technology-control encumbrances — URENC and Orano cascades on US soil operate under foreign technology-sharing restrictions that bar them from HALEU and defense work. The centrifuge designs are classified and export-controlled, the manufacturing know-how took two decades and billions of federal dollars to rebuild, and the security-cleared workforce cannot be assembled quickly. This is a physical, national-security engineering moat that no software or foreign entrant can replicate on a relevant timeline.
- Contracted Backlog & Sole-Source Government Demand: Centrus carries a ~$3.8B revenue backlog extending to 2040 across its LEU (enriched uranium for existing reactors) and Technical Solutions (HALEU and engineering) segments. Long-term SWU supply contracts lock in utilities, while the US government is effectively a captive customer: re-establishing a domestic enrichment base is a stated policy goal, and Centrus is the only vendor that can deliver it. June 2026 brought a non-binding LOI with Oklo for fuel supply, an early signal that commercial HALEU offtake is beginning to convert the policy tailwind into private demand.
Moat Verdict
Centrus is a net beneficiary of AI adoption through the data-center nuclear-power tailwind — AI-driven electricity demand is accelerating the SMR buildout that HALEU fuels, and Centrus is the only Western supplier of that fuel. Its core moats — classified centrifuge technology, the sole NRC HALEU license, and sole-source government demand — are physical and regulatory advantages entirely immune to AI-driven disruption; the real risk is commercial and political (SMR deployment pace and appropriations), not technological obsolescence.
57.8 resilient · 65.0 vulnerable · 80/20 = 59.2 · = 59
Open a moat to read its note.
Centrus sells enriched uranium and HALEU as a commodity fuel; there is no user-trained interface or workflow creating switching costs, so this moat category does not apply.
Not software business logic: the AC100M centrifuge is classified, export-controlled enrichment hardware and manufacturing know-how. That barrier is scored under regulatory lock-in (the NRC licence and national-security controls), not here — the same convention as Cameco.
Centrus does not control any unique public data source; this moat category does not apply to a uranium enrichment business.
Centrifuge engineers, enrichment physicists, and NRC-qualified, security-cleared nuclear technicians are a scarce discipline with multi-year clearance timelines; Centrus holds essentially the only assembled US enrichment workforce, though competition for nuclear talent from SMR developers and utilities creates some retention pressure.
Centrus bundles enriched uranium (SWU), HALEU production, transportation, and fuel-cycle engineering services into an integrated offering that utilities and the DOE value for supply security, though technically sophisticated buyers could in principle source components separately.
Centrus holds decades of proprietary centrifuge-performance and enrichment-operations data from the American Centrifuge and Megatons-to-Megawatts programs, but it is not a compounding, network-scale data asset — its durability comes from physical technology and regulatory position rather than data accumulation.
Centrus is the first and sole NRC-licensed HALEU producer in the Western world and the only US-owned enrichment operator; before it, the only commercial HALEU supplier was Russia's Rosatom. Enrichment sits behind NRC licensing, non-proliferation and export controls, and the $900M DOE HALEU task order (Jan 2026) makes Centrus the default vendor for US nuclear-fuel policy.
Enrichment is a commodity-style fuel service with no Metcalfe's-Law dynamics — the value of Centrus's product does not increase as more utilities buy it; the only network-adjacent effect is the deepening of utility and government relationships as the installed reactor base grows.
Multi-year SWU supply contracts and sole-source DOE HALEU task orders embed Centrus as the default Western enrichment supplier with a ~$3.8B backlog to 2040; switching enrichers requires re-contracting, security vetting, and government approvals, making mid-program switching prohibitive for utilities and effectively impossible for the US government, which has no domestic alternative.
Centrus is not a system of record for any information function; this moat category does not apply to a uranium enrichment business.
Sub-scale enrichment capacity versus Urenco, Orano and Rosatom; the HALEU position is a licensing monopoly (rated under regulatoryLockIn), not a cost lead.
Sells a fungible product or capacity: buyers pay the market price, not a brand premium.
Combined average of Moat (AI Resilience), Growth, and Valuation scores.
Moat Score
Centrus's moat rests on being the only US-owned-and-operated uranium enrichment technology and the first and sole NRC-licensed producer of HALEU in the Western world — a national-security barrier reinforced by a ~$3.8B contracted backlog stretching to 2040 and sole-source US Department of Energy funding for the Piketon, Ohio cascade.
Growth Score
Q2 2026 revenue rose to $176.1M from $154.5M (+14% YoY), with GAAP net income of $16.8M (vs $28.9M) and adjusted net income of $38.7M; the LEU segment grew 22% to $153.4M on uranium sales while SWU revenue fell on 23% lower volume, and Technical Solutions fell 21% to $22.7M on lower HALEU Operation Contract revenue. Management reaffirmed FY2026 revenue guidance of $450–500M, signed the $900M HALEU enrichment award contract with the DOE, grew the contingent LEU and HALEU enrichment backlog to $3.0B, and signed a first large-scale commercial HALEU supply agreement that may include prepayments. The expansion capacity is years from revenue, so the slope still depends on federal appropriations cadence and the pace at which SMR developers actually deploy.
Valuation Score
At ~$190 the stock has rallied several-fold on the HALEU thesis and sits modestly above a base case of ~$175 — fairly valued leaning rich, with JPMorgan at a $236 Hold; current earnings ($10M quarterly) are thin relative to a ~$3.8B market cap, so the price already discounts substantial HALEU success and leaves little margin of safety.
The Western Enrichment Monopoly
Centrus owns the only domestic US uranium-enrichment capability at a moment when re-shoring the nuclear fuel cycle away from Russia's Rosatom has become explicit US energy and national-security policy:
- The Only Western HALEU Producer: High-Assay Low-Enriched Uranium (HALEU, 5–20% U-235) is the fuel required by nearly every advanced and small modular reactor design — Oklo, X-energy, TerraPower — yet before Centrus the only commercial supplier on Earth was Russia's Rosatom. Centrus is the first and only company to receive an NRC license to produce HALEU and the only Western enricher actually producing it at its Piketon, Ohio plant. That first-mover regulatory position, paired with a multi-year US Department of Energy production contract and a $900M task order (January 2026) to build commercial-scale capacity, makes Centrus the default fuel supplier for the entire Western SMR industry.
- American Centrifuge: Classified, Export-Controlled Technology: The AC100M centrifuge is the only US-origin enrichment machine and the only enrichment technology that is both American-owned and free of foreign technology-control encumbrances — URENC and Orano cascades on US soil operate under foreign technology-sharing restrictions that bar them from HALEU and defense work. The centrifuge designs are classified and export-controlled, the manufacturing know-how took two decades and billions of federal dollars to rebuild, and the security-cleared workforce cannot be assembled quickly. This is a physical, national-security engineering moat that no software or foreign entrant can replicate on a relevant timeline.
- Contracted Backlog & Sole-Source Government Demand: Centrus carries a ~$3.8B revenue backlog extending to 2040 across its LEU (enriched uranium for existing reactors) and Technical Solutions (HALEU and engineering) segments. Long-term SWU supply contracts lock in utilities, while the US government is effectively a captive customer: re-establishing a domestic enrichment base is a stated policy goal, and Centrus is the only vendor that can deliver it. June 2026 brought a non-binding LOI with Oklo for fuel supply, an early signal that commercial HALEU offtake is beginning to convert the policy tailwind into private demand.
Moat Verdict
Centrus is a net beneficiary of AI adoption through the data-center nuclear-power tailwind — AI-driven electricity demand is accelerating the SMR buildout that HALEU fuels, and Centrus is the only Western supplier of that fuel. Its core moats — classified centrifuge technology, the sole NRC HALEU license, and sole-source government demand — are physical and regulatory advantages entirely immune to AI-driven disruption; the real risk is commercial and political (SMR deployment pace and appropriations), not technological obsolescence.
57.8 resilient · 65.0 vulnerable · 80/20 = 59.2 · = 59
Open a moat to read its note.
Centrus sells enriched uranium and HALEU as a commodity fuel; there is no user-trained interface or workflow creating switching costs, so this moat category does not apply.
Not software business logic: the AC100M centrifuge is classified, export-controlled enrichment hardware and manufacturing know-how. That barrier is scored under regulatory lock-in (the NRC licence and national-security controls), not here — the same convention as Cameco.
Centrus does not control any unique public data source; this moat category does not apply to a uranium enrichment business.
Centrifuge engineers, enrichment physicists, and NRC-qualified, security-cleared nuclear technicians are a scarce discipline with multi-year clearance timelines; Centrus holds essentially the only assembled US enrichment workforce, though competition for nuclear talent from SMR developers and utilities creates some retention pressure.
Centrus bundles enriched uranium (SWU), HALEU production, transportation, and fuel-cycle engineering services into an integrated offering that utilities and the DOE value for supply security, though technically sophisticated buyers could in principle source components separately.
Centrus holds decades of proprietary centrifuge-performance and enrichment-operations data from the American Centrifuge and Megatons-to-Megawatts programs, but it is not a compounding, network-scale data asset — its durability comes from physical technology and regulatory position rather than data accumulation.
Centrus is the first and sole NRC-licensed HALEU producer in the Western world and the only US-owned enrichment operator; before it, the only commercial HALEU supplier was Russia's Rosatom. Enrichment sits behind NRC licensing, non-proliferation and export controls, and the $900M DOE HALEU task order (Jan 2026) makes Centrus the default vendor for US nuclear-fuel policy.
Enrichment is a commodity-style fuel service with no Metcalfe's-Law dynamics — the value of Centrus's product does not increase as more utilities buy it; the only network-adjacent effect is the deepening of utility and government relationships as the installed reactor base grows.
Multi-year SWU supply contracts and sole-source DOE HALEU task orders embed Centrus as the default Western enrichment supplier with a ~$3.8B backlog to 2040; switching enrichers requires re-contracting, security vetting, and government approvals, making mid-program switching prohibitive for utilities and effectively impossible for the US government, which has no domestic alternative.
Centrus is not a system of record for any information function; this moat category does not apply to a uranium enrichment business.
Sub-scale enrichment capacity versus Urenco, Orano and Rosatom; the HALEU position is a licensing monopoly (rated under regulatoryLockIn), not a cost lead.
Sells a fungible product or capacity: buyers pay the market price, not a brand premium.
Growth Analysis
Growth Drivers
Key Risk
HALEU demand beyond the DOE is contingent on SMR developers (Oklo, X-energy, TerraPower) reaching commercial deployment on schedule and on continued Congressional appropriations; a funding lapse or multi-year SMR slip through 2027–2029 would strand the second cascade and de-rate the equity sharply.
Score Derivation
77.1 base − 10 risk = 67
Base 77.1 (10–16% CAGR, midpoint 13%, baseFromCagr) + 0 trajectory (uranium sales accelerating, SWU enrichment stable, Technical Solutions decelerating) + 0 stable margin (gross margin fell to ~28% from ~35% on mix — uranium cost of sales rose with volume — while LEU segment gross profit rose 2% and SWU price rose 3%, so this is mix, not a per-unit compression) − 10 high keyRisk (appropriations and SMR deployment timing are still unmaterialised, and the grade matches the other uranium-cycle names, CCJ and UEC). The old author string added +3 for TAM expansion; primaryType no longer scores, and the formula computed 73 on the old inputs = 67
Price Scenarios (12–24 Months)
Where We Are vs Targets
Loading live price…
Commercial HALEU demand disappoints as SMR deployments slip, appropriations for the Piketon expansion arrive in fits and starts, SWU prices soften as enrichment capacity normalizes, and the market re-rates a pre-earnings story back toward tangible cash flows.
- SMR developers (Oklo, X-energy, TerraPower) push first commercial reactor dates from the late-2020s into the 2030s; non-DOE HALEU offtake fails to materialize and the second cascade is deferred, leaving Centrus dependent on lumpy government task orders
- A Congressional appropriations lapse or continuing-resolution gridlock delays funding for the Piketon expansion; the DOE backlog converts to revenue more slowly than guided and FY2027 revenue lands below $450M
- Russian/Rosatom enrichment re-enters Western markets via waivers or sanctions easing, and incremental URENC/Orano capacity comes online — SWU spot prices fall and Centrus's pricing power on legacy LEU contracts compresses
The HALEU ramp proceeds on the DOE backlog, the first commercial offtake LOIs (Oklo and peers) convert to binding contracts, SWU prices stay firm on de-risking from Russian supply, and revenue scales toward $600M+ by 2028 — but the equity digests its multi-year rally and trades roughly sideways to modestly higher.
- Piketon HALEU production scales on schedule under the $900M task order; Technical Solutions revenue continues compounding ~30–40% and the segment turns reliably profitable by FY2027
- One to two SMR developers convert LOIs into binding multi-year HALEU offtake agreements, validating commercial (non-DOE) demand and underwriting financing for the second enrichment cascade
- Long-term SWU contracting stays firm as US and European utilities continue diversifying away from Rosatom; the LEU segment delivers steady, contracted cash flow that funds the HALEU buildout
HALEU becomes the binding bottleneck for the Western SMR and AI-datacenter nuclear buildout, Centrus signs multiple binding commercial offtakes, the second cascade is financed and expanded, and earnings inflect as the only Western supplier prices scarce fuel into a supply-constrained market.
- HALEU demand outruns Centrus's near-term capacity as the SMR pipeline and AI-driven nuclear PPAs accelerate; the company finances a materially larger second cascade and signs binding offtakes at premium pricing, capturing the $8B-by-2035 HALEU TAM
- A second DOE/national-security award (or allied-government contract) expands the enrichment base, cementing Centrus as the strategic Western enrichment champion and adding a defense/space (HALEU and tritium-adjacent) demand leg
- SWU spot prices spike on a structural Western supply deficit as Rosatom is durably excluded; the legacy LEU segment's cash flow inflects and the combined business re-rates from a story stock to a profitable, contracted compounder